Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Infusion of Ketamine in Severe Borderline Personality Disorder

Tundra lists 1 Infusion of Ketamine in Severe Borderline Personality Disorder clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

NOT YET RECRUITING

NCT07099534

Ketamine Infusion for Symptomatic Improvement in Severe Borderline Personality Disorder

The main objective of this pilot study is to evaluate at D9 the evolution of BPD symptoms' intensity(scale BSL-23) in severe BPD patients, after two Ketamine infusions (0.5mg/kg at H0 and H24). The intervention is combined with the first level standard of care : Good Psychiatric Management (GPM). Patients are followed up to 3 months by regular visits conducted by a psychiatrist. Secondary outcomes are monitored including BPD symptoms at different times, suicidal ideation, depressiv symptoms, healthcare use and adverse effects.

Gender: All

Ages: 18 Years - 65 Years

Updated: 2025-08-11

Infusion of Ketamine in Severe Borderline Personality Disorder

Borderline Personality Disorder (BPD)